Benchmark's interim results confirm the limited damage of a Salmosan generic launching in Chile this year. However, this story remains so much more. With the new Breeding & Genetics division (BBG) leading from the front, the opportunities for this broad-based animal health-to-sustainability science Group look set to deliver significant earnings growth.

29 Jun 2015
A clear growth path

Sign up for free to access
Get access to the latest equity research in real-time from 12 commissioned providers.
Get access to the latest equity research in real-time from 12 commissioned providers.
A clear growth path
Benchmark Holdings Plc (BHCCF:OTC) | 0 0 0.0% | Mkt Cap: 323.8m
- Published:
29 Jun 2015 -
Author:
Robin Campbell -
Pages:
11 -
Benchmark's interim results confirm the limited damage of a Salmosan generic launching in Chile this year. However, this story remains so much more. With the new Breeding & Genetics division (BBG) leading from the front, the opportunities for this broad-based animal health-to-sustainability science Group look set to deliver significant earnings growth.